11 min read
Monthly FDA Guidance and Regulatory News Review - September 2026
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.
Learn More →
Meet Veristat at the EMSO 2017 Congress, the most influential annual meeting for oncology professionals in Europe. This year's theme "Integrating science into oncology for a better patient outcome" echos the call across the industry to develop more targeted therapies to extend and improve the lives off cancer patients.
Our teams’ have the expertise and experiences to help you design, build, and run your oncology/hematology clinical development program. And, we’ll help you navigate the regulatory submission process.
Fill out the form on the right hand side of this page to schedule a time to meet with Veristat at ESMO. Even if you are not attending ESMO and want to speak with one of Veristat's experts, fill out the form.
Learn how Veristat helped a current client achieve their patient enrollment timeline for an early phase oncology clinical trial.
11 min read
Oct 21, 2026 Veristat Blog
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
8 min read
Sep 21, 2026 Veristat Blog
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...